SMGZY

Smiths Group plc [SMGZY] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

SMGZY Stock Summary

Earnings have grown 18.36% per last year.

EPS has been increasing for the past 3 quarters (Quarter statements)

Earnings are expected to fall -100% next year

Unstable dividend track record

Top 10 Correlated ETFs

SMGZY

Top 10 Correlated Stocks

SMGZY

In the News

SMGZY Financial details

Company Rating

Buy

Market Cap

7.11B

Income

222M

Revenue

5.6B

Book val./share

6.81

Cash/share

0.59

Dividend

0.51

Dividend %

2.38%

Employees

15.16K

Optionable

Shortable

Yes

Earnings

20 Sep 2019

P/E

25.72

Forward P/E

PEG

0.15

P/S

1.92

P/B

2.49

P/C

33.34

P/FCF

27.46

Quick Ratio

1.24

Current Ratio

1.94

Debt / Equity

0.27

LT Debt / Equity

EPS (TTM)

0.61

EPS next Y

EPS next Q

EPS this Y

1870.15%

EPS next Y

EPS next 5Y

EPS last 5Y

12.89%

Revenue last 5Y

3.98%

Revenue Q/Q

2.87%

EPS Q/Q

20.69%

SMA20

-2.65%

SMA50

-2.65%

SMA100

-1.17%

Inst Own

Inst Trans

ROA

ROE

ROC

0.12%

Gross Margin

37%

Oper. Margin

13%

Profit Margin

Payout

62%

Shs Outstand

Shs Float

Target Price

52W Range

18.49-23.22

52W High

-14.48%

52W Low

+9.28%

RSI

36.53

Rel Volume

0.91

Avg Volume

8.95K

Volume

8.13K

Perf Week

-2.62%

Perf Month

-4.47%

Perf Quarter

4.85%

Perf Half Y

1.24%

Beta

0.654

Volatility

0.38%, 0.42%

Prev Close

-0.1%

Price

19.67

Change

-0.41%

SMGZY Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-07-31

Metric	2019-07-31	2020-07-31	2021-07-31	2022-07-31	2023-07-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	6.27	6.39	6.04	6.61	8.56
Net income per share	0.36	0.17	0.39	0.03	0.65
Operating cash flow per share	0.87	1.08	1.34	0.72	0.83
Free cash flow per share	0.57	0.8	1.05	0.49	0.6
Cash per share	0.48	0.58	0.67	2.53	0.58
Book value per share	5.92	5.95	6.03	6.95	6.72
Tangible book value per share	1.75	2.08	2.32	2.92	2.5
Share holders equity per share	5.92	5.95	6.03	6.95	6.72
Interest debt per share	3.96	4.06	3.9	3.15	2.08
Market cap	6.53B	5.38B	6.16B	5.87B	6.05B
Enterprise value	7.75B	6.57B	7.25B	5.98B	6.42B
P/E ratio	45.98	80.23	39.21	451.43	26.19
Price to sales ratio	2.61	2.11	2.56	2.29	1.99
POCF ratio	18.87	12.53	11.51	21.03	20.65
PFCF ratio	28.64	16.85	14.73	30.73	28.53
P/B Ratio	2.77	2.27	2.56	2.17	2.54
PTB ratio	2.77	2.27	2.56	2.17	2.54
EV to sales	3.1	2.58	3.01	2.33	2.11
Enterprise value over EBITDA	13.36	18.25	17.15	18.62	10.27
EV to operating cash flow	22.4	15.32	13.56	21.43	21.91
EV to free cash flow	33.99	20.6	17.35	31.3	30.28
Earnings yield	0.02	0.01	0.03	0	0.04
Free cash flow yield	0.03	0.06	0.07	0.03	0.04
Debt to equity	0.64	0.66	0.63	0.43	0.27
Debt to assets	0.28	0.29	0.28	0.22	0.15
Net debt to EBITDA	2.1	3.32	2.59	0.34	0.59
Current ratio	2.94	2.76	2.77	1.73	1.94
Interest coverage	6.33	4.02	6.39	3.31	4.74
Income quality	0.73	1.07	1.26	2.05	0.72
Dividend Yield	0.03	0.02	0.03	0.03	0.02
Payout ratio	1.25	1.88	1.18	11.54	0.62
Sales general and administrative to revenue	0.15	0.15	0.15	0.14	0.13
Research and developement to revenue	0.03	0.03	0.03	0.03	0.02
Intangibles to total assets	0.32	0.29	0.28	0.3	0.35
Capex to operating cash flow	-0.34	-0.26	-0.22	-0.32	-0.28
Capex to revenue	-0.05	-0.04	-0.05	-0.03	-0.03
Capex to depreciation	-0.86	-0.76	-0.84	-0.68	-0.6
Stock based compensation to revenue	0.01	0	0.01	0.01	0
Graham number	6.89	4.74	7.31	2.29	9.92
ROIC	0.05	0.03	0.05	0.01	0.08
Return on tangible assets	0.04	0.02	0.04	0	0.08
Graham Net	-4.96	-5.21	-4.89	-1.65	-2.27
Working capital	1.78B	1.77B	1.75B	1.02B	848M
Tangible asset value	697M	830M	925M	1.13B	885M
Net current asset value	-237M	-253M	-178M	-84M	-203M
Invested capital	0.64	0.66	0.63	0.43	0.27
Average receivables	745M	700M	664.5M	736M	809.5M
Average payables	232.5M	199.5M	183M	235M	264.5M
Average inventory	441.5M	431.5M	413.5M	475.5M	603.5M
Days sales outstanding	109.59	93.11	103.01	112.8	99.27
Days payables outstanding	56.45	41.67	46.02	64.13	46.98
Days of inventory on hand	106.51	104.42	93.27	129.63	121.16
Receivables turnover	3.33	3.92	3.54	3.24	3.68
Payables turnover	6.47	8.76	7.93	5.69	7.77
Inventory turnover	3.43	3.5	3.91	2.82	3.01
ROE	0.06	0.03	0.07	0	0.1
Capex per share	-0.3	-0.28	-0.29	-0.23	-0.23

Quarterly Fundamentals Overview

Last date of statement is 2023-07-31 for Q4

Metric	2021-07-31	2022-01-31	2022-07-31	2023-01-31	2023-07-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	3.14	3.01	3.8	4.19	4.4
Net income per share	0.39	0.26	-0.29	0.29	0.35
Operating cash flow per share	0	0	0	0.28	0.55
Free cash flow per share	0	0	0	0.18	0.42
Cash per share	0.67	4.07	2.72	1.94	0.59
Book value per share	6.01	7.95	7.46	6.94	6.81
Tangible book value per share	2.31	4.21	3.13	2.53	2.53
Share holders equity per share	6.01	7.95	7.46	6.94	6.81
Interest debt per share	3.82	3.82	3.31	3.49	1.96
Market cap	6.17B	6.14B	5.47B	6.14B	5.97B
Enterprise value	7.27B	5.91B	5.58B	6.55B	6.34B
P/E ratio	9.89	15.19	-13.14	14.9	12.23
Price to sales ratio	4.91	5.15	3.98	4.1	3.87
POCF ratio	0	0	0	61.41	30.92
PFCF ratio	0	0	0	95.95	40.32
P/B Ratio	2.57	1.95	2.03	2.48	2.5
PTB ratio	2.57	1.95	2.03	2.48	2.5
EV to sales	5.79	4.96	4.06	4.38	4.11
Enterprise value over EBITDA	26.72	25.93	121.23	23.32	21.7
EV to operating cash flow	0	0	0	65.54	32.83
EV to free cash flow	0	0	0	102.4	42.81
Earnings yield	0.03	0.02	-0.02	0.02	0.02
Free cash flow yield	0	0	0	0.01	0.02
Debt to equity	0.63	0.47	0.43	0.49	0.27
Debt to assets	0.28	0.25	0.22	0.24	0.15
Net debt to EBITDA	4.03	-0.99	2.39	1.47	1.26
Current ratio	2.77	2.55	1.73	1.61	1.94
Interest coverage	8.7	6.79	-0.58	5.58	6.85
Income quality	0	0	0	0.97	1.58
Dividend Yield	0	0	0	0.02	0.01
Payout ratio	0	0	0	0.94	0.38
Sales general and administrative to revenue	0.16	0.17	0.16	0.15	0
Research and developement to revenue	0.03	0.04	0.02	0.03	0.02
Intangibles to total assets	0.28	0.26	0.3	0.32	0.35
Capex to operating cash flow	0	0	0	-0.36	-0.23
Capex to revenue	0	0	0	-0.02	-0.03
Capex to depreciation	0	0	0	-0.52	-0.68
Stock based compensation to revenue	0	0	0	0.01	0
Graham number	7.27	6.76	6.95	6.71	7.31
ROIC	0.04	0.02	-0.01	0.03	0.05
Return on tangible assets	0.04	0.02	-0.03	0.03	0.04
Graham Net	-4.87	-0.91	-1.77	-2.51	-2.3
Working capital	1.75B	1.74B	1.02B	857M	848M
Tangible asset value	925M	1.67B	1.13B	903M	885M
Net current asset value	-178M	144M	-84M	-240M	-203M
Invested capital	0.63	0.47	0.43	0.49	0.27
Average receivables	637M	685.5M	742.5M	777M	793.5M
Average payables	329.5M	384M	431M	485.5M	468M
Average inventory	387.5M	414M	508.5M	630M	663.5M
Days sales outstanding	48.65	52.25	51.94	45.75	48.27
Days payables outstanding	20.94	68.5	28.39	63.86	22.23
Days of inventory on hand	42.44	52.8	57.38	63.95	57.33
Receivables turnover	1.85	1.72	1.73	1.97	1.86
Payables turnover	4.3	1.31	3.17	1.41	4.05
Inventory turnover	2.12	1.7	1.57	1.41	1.57
ROE	0.06	0.03	-0.04	0.04	0.05
Capex per share	0	0	0	-0.1	-0.13

SMGZY Dividend History

SMGZY Frequently Asked Questions

What is Smiths Group plc stock symbol ?

Smiths Group plc is a GB stock and trading under the symbol SMGZY

What is Smiths Group plc stock quote today ?

Smiths Group plc stock price is $19.67 today.

Is Smiths Group plc stock public?

Yes, Smiths Group plc is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 8.95K
Market Capitalization 7.11B
Employee 15.16K
CEO Mr. Paul A. Keel
Headquarters London,GB
IPO Date 2010-11-02
Website https://www.smiths.com

Smiths Group plc operates as a technology company serving the medical technology, security and defense, general industrial, energy, and space and aerospace markets worldwide. It operates through John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect, and Smiths Medical divisions. The John Crane division offers mechanical seals, seal support systems, hydrodynamic bearings, packing materials, power transmission couplings, and specialized filtration systems. The Smiths Detection division provides sensors and systems that detect and identify explosives, narcotics, weapons, chemical agents, biohazards, and contraband. The Flex-Tek division offers engineered components that heat and move fluids and gases for the aerospace, medical, industrial, construction, and domestic appliance markets. The Smiths Interconnect division provides specialized electronic and radio frequency board-level and waveguide devices, connectors, cables, test sockets, and sub-systems for applications in the security and defense, medical, general industrial, and space and aerospace markets. The Smiths Medical division offers infusion systems, vascular access, patient airway, and temperature management equipment products; and specialised devices in areas of diagnostic and emergency patient transport. The company was formerly known as Smiths Industries and changed its name to Smiths Group plc in 2000. Smiths Group plc was founded in 1851 and is headquartered in London, the United Kingdom.